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vitamin B2) plays a key role in energy metabolism as a 
source of flavin mononucleotide (riboflavin-5′-phosphate, 
FMN) and flavin adenine dinucleotide (FAD). Moreover, 
it is a component of the flavin enzymes and coenzymes, 
which carry electrons in oxidation and reduction 
reactions, and it also plays a key role in the respiratory 
chain and the oxidation of fatty acids and amino acids. 
Furthermore, riboflavin is involved in the Krebs cycle 
and the metabolism of folate, vitamin B6, (pyridoxine), 
and vitamin B12 (cobalamin) (1). Riboflavin plays an 
important role in the innate immunity of both plants and 
animals (1–3). The immunomodulatory role of riboflavin 
in avian immunity is particularly highly appreciated (3). 
In vertebrates, flavin deficiencies lead to diseases 
such as glossitis, cheilosis, and organic acidurias (4). A 
deficiency of riboflavin is very rare in adult birds; however, 
its disappearance from the organism is associated with the 
overall hypovitaminosis (5–7). In avian species, riboflavin 
is required for proper embryonic development; therefore, 
it is accumulated in the developing chicken egg at an 
amount of about 300 µg per egg (8). Riboflavin deficiency 
is often related to mutations in an Rd gene encoding a 
riboflavin-binding protein (RfBP), which is responsible 
for deposition of riboflavin in eggs (9). In rd/rd mutants, 
effects of deficiency become apparent after day 10 of 
incubation (5). Embryo death occurs suddenly around 
day 13 of incubation and is the result of inhibition of 
activity of flavin-dependent enzymes, hypoglycemia, and 
impaired fatty acid oxidation. The adverse effects of the Rd 
gene mutation can be abolished by in ovo administration 
of free riboflavin or FMN but not RfBP (10). Riboflavin-
supplemented embryos survived and developed properly, 
but those injected with RfBP died. This indicates that the 
unbound riboflavin that is injected into egg whites can 
be used by the developing embryo to ensure its proper 
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development, while the injected apo-RfBP is detrimental. 
The fates of embryos were dependent on the relative 
amounts of the injected riboflavin and RfBP; excess of 
the latter diminished the availability of riboflavin to the 
chicken embryos, leading to their mortality (10).
In humans and other mammals, the relationship 
between plasma concentrations of riboflavin and thyroid 
hormones (THs) has been already described. It has been 
established that 3,3’,5-triiodo-L-thyronine (T3) regulates 
flavocoenzyme biosynthesis by determining the activities 
of flavocoenzyme-forming enzyme (11,12). Possibly, 
low concentrations of B vitamins adversely influence 
the hypophysis, pituitary gland, and/or thyroid gland 
functions (12). 
The chicken embryo is the most useful and sensitive 
model for drugs, xenobiotics, and vitamin investigations 
(5,13–16). Nevertheless, in the available literature there are 
no data showing the influence of riboflavin on the function 
of the hypothalamo–pituitary–thyroid (HPT) axis during 
chicken embryogenesis. Taking into consideration that 
THs play a crucial role during chicken embryogenesis and 
affect the time of hatching and the length of incubation 
(17,18), the present study was designed to answer the 
question of whether the supplementation of the chicken 
embryo with riboflavin may change 3,3’,5,5”-tetraiodo-
L-thyronine (thyroxine; T4) and T3 levels in blood 
circulation. Consequently, in this study the effects of this 
vitamin on body and organ weight, as well as the hatching 
parameters of embryo mortality and timing of external 
pipping and hatching (during the last days of incubation), 
were determined to find out the possible linkage between 
the thyroid gland function (affected by riboflavin) and 
embryonic development.
2. Materials and methods
2.1. Experimental design 
The experimental and animal procedures were approved 
by the Local Animal Ethics Committee in Krakow. Eggs of 
the parental broiler line Ross 308 (Aviagen) were used in 
the experiment. Before the start of incubation, eggs were 
numbered and weighed. Incubation was carried out in an 
incubator (Massales 65, Spain) under standard conditions 
(temperature of 37.8 °C; relative humidity of 50%), and 
eggs were turned once an hour at an angle of 90° during 
days of incubation from days 1 to 18 (E1–E18). During 
incubation, eggs were candled on days 6, 8, and 18 (E6, 
E8, and E18). During E6 candling, eggs with unfertilized 
and dead embryos were discarded, while in E8 candling, 
embryos that died after injection were removed. On 
E18, candled eggs with evidence of living embryos were 
transferred from the turning trays into hatcher baskets and 
incubation was continued at 37.2 °C and 55%–65% relative 
humidity. 
The sixth day of incubation was considered optimal to 
carry out in ovo supplementation according to previous 
experiments and publications (13–15), in order to reduce 
the sensitivity of the embryo to manipulation and to ensure 
the action of administered substances for the longest 
period. Eggs candled on E6 with living embryos (n = 600) 
were divided into 3 equal groups, which were injected with 
riboflavin at doses of 0 (control), 60, or 600 µg/egg. The 
lower dose of riboflavin was based on the publication of 
Lee and White (10) as a minimum quantity of this vitamin 
sufficient for the proper development of the chick embryo, 
while the higher dose exceeds by about 2 times the amount 
of riboflavin contained in the chicken egg (8). 
Riboflavin (R9504, Sigma, USA) was dissolved in 50 
µL of sterile 0.7% NaCl solution (Polpharma SA, Poland). 
Before the injection, the shell at the site of the injection 
was disinfected with 70% ethanol and a window was made 
in the eggshell (diameter of about 5 mm). Injection was 
performed using a pipette with 100 µL volume tips via the 
air chamber at a depth of 5 mm under the chorioallantoic 
membrane to the albumin without injuring the blood 
vessels and the amnion. The riboflavin solution was stored 
in a light-impervious vessel. After injection, the hole was 
sealed with Parafilm tape (Sigma) and eggs from every 
group were subsequently divided to into 2 subgroups: 
1) a “hatchability” subgroup for checking hatchability 
and course of hatch (n = 145 eggs per group) and 2) a 
“sampling” subgroup for tissue sampling (n = 55 per 
group). Incubation was then continued under normal 
conditions.
2.2. Hatching course and result of hatch analyses
All eggs discarded during candling or unhatched from 
the “hatchability” subgroups were analyzed for the stage 
of development and malformations. Moreover, on E18 
candled eggs from these subgroups with evidence of living 
embryos were transferred to hatching baskets and used to 
monitor the course of the hatching process. The process 
of hatching was checked every 2 h from the 460th hour 
of incubation. The time of external pipping and the time 
of hatching of each chick were recorded. At the end of the 
experiment, the unhatched eggs were broken and the stage 
of embryonic development was noted (8,19). 
2.3. Blood sampling, body and organ weight recording, 
and hormone analysis in plasma
Blood samples were collected from 12 randomly selected 
embryos of each “sampling” subgroup on E12, E15, E18 
(stage before internal pipping), and E20 (stage of external 
pipping). Blood was sampled into test tubes with heparin 
(Coaparin, Polfa Warsaw Ltd., Poland). Plasma samples 
were kept at –20 °C until hormone determination. After 
blood collection, each embryo was drained and body 
weights were recorded. Subsequently, the heart and liver 
were dissected and weighed. 
232
TRZECIAK et al. / Turk J Vet Anim Sci
Thyroid hormone T4 and T3 concentrations in plasma 
samples were determined by means of radioimmunoassay 
using T4 and T3 kits (BRAHMS, Germany). The lowest 
limits of T4 and T3 assay sensitivity were 0.7 ng/mL and 
0.09 ng/mL, and mean recoveries as performed in our 
laboratory were 96.3% and 95.0%, respectively. The 
intra- and interassay coefficients of variation for T4 and 
T3 analysis were 4.0% and 5.3%, and 3.5% and 6.3%, 
respectively. The cross-reactions of T4 antibodies with 
T3 and rT3 (3,3’,5’-triiodo-L-thyronine) were <0.2% and 
5%, respectively, while with other iodothyronines and 
iodothyronine-like compounds they were below 0.5%. 
The cross-reaction of T3 antibodies with T4 was 0.06%, 
and with other iodothyronines and iodothyronine-like 
particles it was below 0.2%.
2.4. Statistical analyses
Results of the pipping and hatching courses were presented 
as medians and means ± SDs and were analyzed by the 
Kruskal–Wallis one-way analysis of variance (ANOVA) on 
ranks for failed normality test. Data of each group were 
demonstrated with a linear regression of y = a + bx, where y 
is percentage of the pipped/hatched chicks; x stands for the 
incubation hour; a is the intercept, i.e. the estimated start 
of the pipping or hatching process; and b is the slope, i.e. 
the degree of the synchronization of pipping or hatching 
processes in the time (h) necessary to pip or hatch 1% of 
the chicks (14,15).
The hatchability and mortality data were statistically 
analyzed by z-test while the results of TH concentrations 
as well as body and organ weight were studied by 2-way 
ANOVA, followed by Tukey’s multiple range test. 
The statistical analyses were performed using Sigma-
Stat 2.03 (SPSS, USA) while figures were made with 
Grapher 8.0 (Golden Software Inc., USA). Because the 
radioimmunoassay revealed that there were no significant 
differences in plasma TH levels between male and female 
embryos during the incubation process, which is in 
agreement with previous findings (20), the data from both 
sexes were combined. The results were presented as mean 
± SEM and were considered significant at P ≤ 0.05 and 
highly significant at P ≤ 0.01.
3. Results
3.1. Embryo hatchability and mortality
Generally, in comparison with the control group, riboflavin 
supplied in ovo did not affect chicken embryo mortality 
and hatchability, except at the dose of 60 µg/egg. In this 
case, many embryos died immediately after manipulation 
(between E6 and E8), resulting in a decrease in hatchability 
by 11% (P ≤ 0.05; Table 1).
ANOVA revealed that the embryonic body weight 
(EBW) was significantly influenced by stage of development 
(P ≤ 0.01) and riboflavin administration (P ≤ 0.05). The 
first effect was evoked by a gradual increase in EBW from 
9.5 ± 0.25 g on E12 to 38.4 ± 0.90 g on E20 in the control 
group. The second was a result of a significant reduction 
of EBW by the higher dose of riboflavin (600 µg/egg) by 
11% and 10% (P ≤ 0.05) on E12 and E15, respectively 
(Figure 1). The relationship between the EBW and stage of 
embryogenesis and dose of riboflavin can be described by 
the following equation: y = –35.496 + 3.606x – 0.003z, R2 
= 0.927, where: y is the body weight of the embryo, x is the 
day of incubation, and z is the dose of riboflavin. 
The weight of the liver and the heart gradually increased 
in all groups during embryogenesis (P ≤ 0.01), but there 
was no significant effect of riboflavin administration on 
the weight of these tissues, nor on their relative weight (P 
> 0.05; data not shown). 
3.2. Course of hatching
Riboflavin treatment did not affect the time of external 
pipping (Table 2). However, statistical analysis of the 
course of hatching revealed that chicks exposed to 60 µg 
Table 1. Effect of in ovo injection of riboflavin at day 6 of incubation on embryonic mortality and chicken hatchability.
Dose of riboflavin (µg per egg)
0 60 600
n % n % n %
Riboflavin-treated embryos (alive at E6) 145 100.0 145 100.0 145 100.0
Embryo mortality in following 
periods of incubation
E6–E8 13 9.0a 30 20.7b 9 6.2a
E9–E17 11 7.6a 13 9.0a 14 9.7a
E18–E21 8 5.5a 5 3.4a 4 2.8a
Hatchability 113 77.9a 97 66.9b 118 81.4a
a, b: values in rows marked with different letters differ significantly (P ≤ 0.05).
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of riboflavin per egg hatched 3.7 h earlier than controls 
(P ≤ 0.05; Table 2). This was caused by a shorter length of 
hatching by 2.1 h (P ≤ 0.05; Table 2). Moreover, chicks from 
this group demonstrated a higher synchronization degree 
of hatching process in comparison with the controls (P ≤ 
0.05; Table 2). Regression equations revealed that 1% of 
chicks treated with 60 µg of riboflavin needed 11.4 min 
for pipping and 7.2 min for hatching, while chicks of the 
control group needed 13.2 and 13.8 min, respectively 
(Table 2). Administration of riboflavin at a dose of 600 µg 
did not influence hatching indicators. 
3.3. Hormone concentration in blood plasma
Concentration of T4 in blood plasma of chicken embryos 
on E12 and E15 was relatively low; however, it significantly 
increased from E18 (P ≤ 0.01; Figure 2a). In the control 
group, on E12 it was 1.88 ± 0.13 ng/mL, and it did not 
change on E15 (Figure 2a). On E18, the plasma level of T4 
sharply increased, reaching a value that was 4.9-fold higher 
in comparison with E15 (P ≤ 0.01). An additional elevation 
in T4 plasma concentration was observed on E20, as it was 
1.2-fold higher in comparison to E18 (P ≤ 0.05; Figure 2a). 
Both applied doses of riboflavin significantly elevated T4 
concentrations in the blood plasma of the chicken embryo 
on E15 by about 60% (P ≤ 0.01). The stimulatory effect of 
riboflavin was also found on E18 and E20; however, only 
the higher dose of riboflavin effectively increased (by 24% 
and 23%, respectively) T4 concentrations (P ≤ 0.05; Figure 
2a). On the other hand, the lower dose of riboflavin (i.e. 60 
µg/egg) significantly reduced T4 levels on E12 by 16% (P ≤ 
0.05; Figure 1a). 
Table 2. Effect of in ovo injection of riboflavin at day 6 of incubation on the hatching process.








hatching (µg/egg) n median mean ±SE (hour of incubation)  (h)
External pipping (EP)
0 117 468a 467.6 ± 0.89a 456.4 ±0.50a 0.22 ± 0.008a
60 99 464a 466.5 ± 0.85a 457.1 ±0.50a  0.19 ± 0.008ab
600 120 468a 469.2 ± 1.97a 457.5 ±0.48a 0.23 ± 0.008a
Hatching (H)
0 113 476b 477.1 ± 0.93b 465.5 ±0.43b 0.23 ± 0.020a
60 97 472b 473.4 ± 0.62c 467.1 ±0.54b   0.12 ± 0.030bc
600 118 480b 478.8 ± 0.89b 467.8 ±0.49b 0.22 ± 0.010a
Length of hatching
(DH = H – EP, h)
0 113 8c 9.0 ± 0.46d - -
60 97 8c 6.9 ± 0.66e - -
600 118 8c 9.8 ± 0.46d - -
Course of chicken hatching was estimated with linear regression y = a + bx, where y is percentage of the pipped/hatched chicks; x stands 
for the incubation hour; a is the intercept, i.e. the estimated start of pipping or hatching process; b is the slope, i.e. the degree of the 
synchronization of pipping or hatching processes in the time (h) necessary to pip or hatch 1% of chicks; Sa is the error of intercept; and 
Sb is the error of slope.
a, b, c, d: values in columns marked with different letters differ significantly (P ≤ 0.05).



























Figure 1. Body weight of chick embryos treated in ovo with 
riboflavin at day 6 of incubation (mean ± SE; n = 12). a, b, c, 
d, e, f: values in same plots marked with different letters differ 
significantly (P ≤ 0.05).
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In the control group, the plasma concentration 
of T3 was 0.90 ± 0.06 ng/m: on E12 (Figure 2b). It was 
significantly decreased (1.45-fold) on E15 (P ≤ 0.05), and 
subsequently, on E18, it rose by 1.8-fold in comparison to 
E15 (P ≤ 0.01). A sharp increase (2.9-fold in comparison 
with E18; P ≤ 0.01) in T3 concentration in blood plasma 
of chicken embryos was observed on E20 (Figure 2b). 
A lower dose of riboflavin (i.e. 60 µg/egg) reduced the 
T3 level by 13% (P ≤ 0.05) on E12; on the other hand, it 
elevated concentration of this hormone by 44% on E15 (P 
≤ 0.01; Figure 2b). There were no significant alterations in 
T3 levels on E18; however, on E20 both applied doses of 
riboflavin decreased T3 levels in blood circulation by 27% 
(P ≤ 0.01) and 19% (P ≤ 0.05), respectively (Figure 2b).
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Figure 2. Concentration of thyroxine (T4) (a), concentration of triiodothyronine (T3) (b), and the molar ratio of T3 to T4 (c) in blood 
plasma of chicken embryos treated in ovo with riboflavin at day 6 of incubation (mean ± SE; n = 12). a, b, c, d, e, f: values in same 
plots marked with different letters differ significantly (P ≤ 0.05).
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The molar T3/T4 ratio is presented in Figure 2c. In the 
control group, a gradual decrease in T3/T4 ratio from 0.49 
± 0.03 on E12 to 0.15 ± 0.02 on E18 was observed (P ≤ 
0.01). A sharp 2.8-fold increase in T3/T4 was found on 
E20 (P ≤ 0.01). The higher dose of riboflavin significantly 
reduced the T3/T4 ratio on E15, E18, and E20 by 46% (P ≤ 
0.01), 16% (P ≤ 0.05), and 20% (P ≤ 0.05), respectively. On 
E20 the lower dose of riboflavin also decreased the molar 
ratio of T3/T4 by 19% (P ≤ 0.05; Figure 2c).
4. Discussion
The results of this experiment reveal that the injection of 
riboflavin at the beginning of embryogenesis may disturb 
the course of chick embryo development. It was found 
that only the lower dose of riboflavin (i.e. 60 µg) decreased 
hatchability by 11%, which was evoked by a significant 
elevation in embryonic mortality (by 20.7%) from 1–2 
days following the manipulation. Taken together with the 
fact that the mortality among the 3 groups did not differ 
on the following days, this suggests that the observed effect 
could also be due to an uncontrolled external factor rather 
than embryo toxicity. This explanation can be supported 
by fact that the sensitivity of the chicken embryo to in ovo 
manipulation is very high at early stages of embryogenesis 
and it decreases gradually during embryonic development. 
It is thought that disturbance in embryo homeostasis 
caused by the applied in ovo manipulation is the main 
reason for its mortality (13). Nevertheless, results of 
experiments performed by Lee and White (10) indicate 
that the fate of an embryo is dependent on the proper ratio 
of RfBP and free riboflavin. In ovo manipulation might 
disturb this ratio, and the temporal excess of apo-RfBP 
might be detrimental to embryos. We may speculate that 
this is one of the reasons for mortality of embryos injected 
with saline or riboflavin during the present experiments. 
Perhaps the low dose of exogenous riboflavin predisposes 
RfBP to diminish its binding properties.
Several lines of evidence indicate that a reduction in 
body weight during the pre- and postembryonic period 
and in chickens (6,21) is associated with a riboflavin 
deficiency. In sharp contrast, in our experiment the 
highest dose of riboflavin (i.e. 600 µg/egg) substantially 
decreased the weight of the chick embryo. A reduction 
in gains was also observed in the growing broiler chicken 
supplemented in ovo with 1.5 and 3 mg of riboflavin 
(22). It cannot be excluded that the reduction in body 
weight following riboflavin treatment is associated with 
an increase in the basal metabolic rate as a result of 
elevation in the activity of flavin-dependent enzymes (i.e. 
flavoprotein monooxygenases, acyl-CoA dehydrogenases, 
or cytochrome P450 reductase) (1). Moreover, riboflavin 
is a cofactor in the conversion of pyridoxine (vitamin B6) 
to pyridoxal phosphate. It seems to be likely that an excess 
of riboflavin accelerates depletion of available pyridoxine. 
Deficiency of vitamin B6 can also be a cause of chicken 
BW loss (21).
The statistical analysis of the course of pipping and 
hatching reveals that the elevation in riboflavin availability 
on E6 may affect the rate of hatching. It can be assumed 
that this is related to changes in the embryonic metabolism 
associated with alterations in TH concentration in blood 
circulation. It is well known that THs play an important 
role in the development of many systems in all vertebrates, 
including birds (23,24). The rapid increase in T3 at the 
end of incubation is necessary not only for stimulation of 
growth and differentiation, but also for preparation of the 
chick for a life outside the egg by regulating processes such 
as yolk sac retraction, the onset of pulmonary respiration, 
hatching, and the initiation of endothermic responses 
(25,26). The low T3 concentration observed during 
most of embryogenesis is a result of high activity of D3 
deiodinase, which in the liver and kidney converts T3 to 
3,3’-diiodo-L-thyronine (3,3’-T2). A sharp increase in T3 
concentration, which appears slightly later in comparison 
with the peak of T4, occurring during the hatching period, 
is associated with the transition of the chick embryo from 
chorioallantoic to pulmonary respiration. It is associated 
with a decrease in activity of D3 deiodinase and elevation 
in activity of D1 deiodinase, which metabolizes T4 to T3 
(23,24). 
In the present experiment alterations in TH 
concentration correspond with the changes described 
above; however, it should be noted that the release of T4 
from the thyroid gland into the blood circulation during 
hatching (i.e. on E20) in the group treated with riboflavin 
at a dose of 600 µg/egg was significantly higher in 
comparison with the control group. On the other hand, at 
the moment of pipping, the concentrations of T3 in blood 
plasma in both experimental groups were significantly 
lower than in the control group. It can be concluded that 
the observed changes in T4 levels are the result of HPT 
axis activity under the influence of riboflavin and changes 
in the metabolism of this hormone in peripheral tissues 
such as the liver. Recently, Grommen et al. (27) revealed 
that the elevated plasma T4 levels observed during the 
last trimester of chicken embryogenesis associated 
with the increased synthesis and secretion of T4 by the 
thyroid gland are caused by the increase in thyroglobulin, 
sodium/iodine symporter, and thyroid peroxidase mRNA 
expression. Therefore, the increased concentration of T4 
on E18 and E20 in the group treated with the highest dose 
of riboflavin might be connected with a direct influence of 
this vitamin on expression of thyroid-specific genes. Nor 
can it be excluded that the increase in T4 concentration 
with a concomitant decrease in T3 level could be evoked by 
the elevation in the iodotyrosine deiodinase (IYD) activity 
as a result of increased availability of FMN as a cofactor 
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for this enzyme. The IYD is the only flavin-dependent 
deiodinase that facilitates the recovery of iodide in the 
thyroid tissue by catalyzing deiodination of mono- and 
diiodotyrosine (28,29). However, in order to verify this 
hypothesis, further studies are needed. 
Because in avian species almost all circulating T3 is of 
peripheral origin (24), it can be assumed that the changes 
in T3 levels following the riboflavin administration are 
the result of its impact on the activity of D1 and D3 
deiodinases. The decrease in T3/T4 ratio in the blood of 
embryos treated with vitamin B2 supports this assumption 
and suggests that riboflavin directly increases the activity 
of D3 deiodinase in the final stages of embryogenesis.
The existence of the specific relationship between 
riboflavin and thyroid gland function observed in our 
experiment has already been postulated. In mammals, it 
has been shown that there is a correlation between the 
levels of riboflavin and concentration of iodothyronines 
in the blood circulation. In humans and rats with 
hypothyroidism, FAD levels decrease in the liver; they 
are similar to those observed in animals fed a vitamin 
B2-deficient diet. This phenomenon results from the T4-
related activity of flavokinase, the enzyme responsible 
for the conversion of vitamin B2 into FMN and FAD. 
Although in the hyperthyroid state the activity of this 
enzyme is doubled, there is no increase in the level of 
FMN and FAD as a result of their increased expenditure 
(30). Therefore, hormone replacement therapy in adults 
with hypothyroidism normalizes the metabolism of 
riboflavin. However, this treatment in newborns with 
congenital thyroid dysfunction does not change the levels 
of vitamin B2 and FMN in the blood, in spite of obtaining 
the appropriate level of iodothyronines (30). 
In summary, riboflavin administration at the early stages 
of embryogenesis markedly affects embryonic development 
and influences thyroid hormone metabolism during the 
second half of embryogenesis. Negative effects of riboflavin 
on hatching success in the present experiments seem to be 
related to the early timing of its administration. Beneficial 
effects of riboflavin on posthatch immunity may be 
expected in birds supplemented in ovo at the final stages of 
development, as has happened in the case of vitamin E (3). In 
order to understand the molecular mechanism of riboflavin 
action in the chicken embryo, more research is needed 
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